photo of researcher in clinical trial
In This Article

Triple-negative breast cancer spreads faster and is tougher to treat than other breast cancers, which makes it harder to survive. And in the U.S., Black women are twice as likely to get it as women of any other race or ethnicity. Yet little of the research includes them. 

“It would make sense in clinical trials focused on triple-negative breast cancer that we see overrepresentation of the patients that are more affected by this subtype of breast cancer,” says Sonya Reid, MD, MPH, a breast oncologist at Vanderbilt-Ingram Cancer Center in Nashville, TN. Her research focuses on health disparities in breast cancer. 

Without Black women in metastatic triple-negative breast cancer research, it’s impossible to answer questions like: 

  • Why are Black women more likely to get this kind of cancer? 
  • Why are Black women more likely to die from it than other women with the same disease? 
  • Do the latest treatments work as well in Black women as in others?

Black people are often excluded directly and indirectly from cancer research, but their participation is critical to improving detection of metastatic triple-negative breast cancer, along with treatment and survival. 

“The drug that you’re receiving today came from a clinical trial yesterday,” Reid says. “That’s why it’s important for all of us to participate regardless of economic situation or race.” 

‘Clinical trials offer the best possible options for treatment’

The benefits of Black women getting in on metastatic triple negative breast cancer research are twofold. 

You can help yourself and other Black women like you in the future. 

“Clinical trials offer the best possible options for treatment, and there are strong data showing that participants have better outcomes for their disease [than those who aren’t in clinical trials],” says Lisa Newman, MD, MPH, a breast surgical oncologist at Weill Cornell Medicine in New York City. She researches racial and ethnic disparities in breast cancer.

Clinical trials might not only offer you better treatments than the current standard care -- especially for a hard-to-treat disease like metastatic triple-negative breast cancer -- but they may provide you with better care overall. 

“In clinical trials, participants are very well-monitored and the entire treatment and follow-up is tightly regulated,” Newman says. 

Research can:

  • Offer you better medication or maybe the only medication you haven’t tried yet.
  • Help explain why certain people or groups are more likely to get the disease than others and lead to more effective prevention and screening methods for these groups.
  • Reveal whether certain treatments work for everyone or only certain groups and lead to better, more customized treatment recommendations for Black women.

Why Black Women Aren’t Getting Into Breast Cancer Research 

Historically, Black people have faced untold racism and discrimination in health care. They’ve also been victims of abuse and unethical treatment in the name of medical research in the past. The Tuskegee Syphilis Study and the case of Henrietta Lacks are some of the best-known incidents, but they are far from the only ones. So it’s no wonder Black people might not be the first to raise their hands to have new cancer drugs tested on them. 

But there is so much more to the lack of diversity in medical research than simply an individual’s lack of trust in the system. 

“I’m not saying we can’t talk about mistrust,” says Reid. “But we have to remember that if you can’t access a clinical trial, whether you are Black or white, you’re not going to be on the clinical trial. It’s as simple as that.” 

The Access Problem

If you want to join a clinical trial, perhaps for a new cancer drug being tested, you have to go to a hospital offering that trial. And you might have to go there often. Clinical trials may mean more tests, monitoring, and doctor visits than regular care. This makes trials expensive and complex. For that reason, researchers don’t run them at every hospital. Clinical trials are usually at large-scale medical centers connected to medical schools. 

Unfortunately, these hospitals are rarely the ones where Black people are most likely to get their cancer care. Up to 85% of people with cancer, regardless of race, use community hospitals close to home. Research shows Black people in particular are more likely than others to get their care at low-resource or underfunded facilities, not places that host clinical trials. 

“Some patients might be able to take off work and drive 2, 3, 4 hours or get on a plane and travel to academic medical centers like Vanderbilt and MD Anderson, but not everybody can do that,” Reid says. “That’s more of a privilege.” 

The National Institute on Minority Health and Health Disparities, a government agency, recently called for researchers to plan studies in a way that would make it easier for people of all backgrounds to participate. The agency recommended offering more convenient hours and locations, childcare services, and transportation vouchers. 

“We have to find a way to include clinical trials in community practices where patients are getting their care from community oncologists they trust,” Reid says. 

Doctors’ Assumptions About Black People

Many doctors, studies show, don’t tell Black patients about research opportunities as often as they tell white patients. They might assume Black patients won’t want to be part of research because of medical mistrust. Some think they are less likely to stay on top of all the requirements, like taking new medicines and making it to all the appointments. 

This unfair assumption keeps Black people out of studies and scientists from learning the unique ways that cancer and its treatments affect them. 

“We have no right to make assumptions about what a patient might be interested in or how they might respond to information about a clinical trial,” Newman says. “If they are an appropriate candidate for a trial, that option has to be offered to them regardless of what they look like.”

The national Just Ask campaign aims to make sure doctors tell all their patients about opportunities to enroll in cancer research. But if your doctor doesn’t tell you about upcoming research, consider mentioning it to them.

How to Get In on Breast Cancer Research

Whether you get your care at an academic medical center or a nearby oncology clinic, ask your doctor if there are clinical trials or other studies that you might be eligible for. 

Clinical trials are mostly for testing medication, medical devices, procedures, or other therapies. If you’re thinking, “I don’t want to be a guinea pig,” there are other ways to help without taking new drugs.

For example, you could sign up for a genetic study about Black women with metastatic triple-negative breast cancer. You’d simply give blood, saliva, or tissue from a tumor. Other research might only require that you answer periodic surveys about your health, family history, lifestyle, and treatment to give researchers more clues about how or why breast cancer affects Black women differently. 

Look for opportunities to participate in research here:

  • Clinicaltrials.gov: A government-sponsored database of information on clinical trials that you can search based on your location and disease.
  • Outcomes4Me: A website and smartphone app that connects people with clinical trials based on their location and medical records.
  • National cancer research organizations such as the American Cancer Society, National Cancer Institute, and Susan G. Komen for the Cure.

Show Sources

Photo Credit: Solskin/Getty Images

SOURCES:

Sonya Reid, MD, MPH, assistant professor of medicine, Division of Hematology/Oncology (Breast Oncology), Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.

Lisa Newman, MD, MPH, FACS, FASCO, professor of surgery, Weill Cornell Medical College, Cornell University, New York, NY.

American Journal of Cancer Research: “Incidence trends in triple-negative breast cancer among women in the United States from 2010 to 2019 by race/ethnicity, age and tumor stage.”

Annals of Surgical Oncology: “Improving the Quality of Cancer Care in Community Hospitals.”

JCO Oncology Practice: “Participation of Black Americans in Cancer Clinical Trials: Current Challenges and Proposed Solutions.”

National Institute on Minority Health and Health Disparities: “Diversity and Inclusion in Clinical Trials.”

Association of Community Cancer Centers: “Just ASK: Increasing Diversity in Cancer Clinical Research.”